Related Experiment Video
Updated: Feb 16, 2026

Assessing Cell Cycle Progression of Neural Stem and Progenitor Cells in the Mouse Developing Brain after Genotoxic Stress
Published on: May 7, 2014
mTOR-Dependent Cell Proliferation in the Brain
Larisa Ryskalin1, Gloria Lazzeri1, Marina Flaibani1
1Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy.
Abstract:
The mammalian Target of Rapamycin (mTOR) is a molecular complex equipped with kinase activity which controls cell viability being key in the PI3K/PTEN/Akt pathway. mTOR acts by integrating a number of environmental stimuli to regulate cell growth, proliferation, autophagy, and protein synthesis. These effects are based on the modulation of different metabolic pathways. Upregulation of mTOR associates with various pathological conditions, such as obesity, neurodegeneration, and brain tumors. This is the case of high-grade gliomas with a high propensity to proliferation and tissue invasion. Glioblastoma Multiforme (GBM) is a WHO grade IV malignant, aggressive, and lethal glioma. To date, a few treatments are available although the outcome of GBM patients remains poor. Experimental and pathological findings suggest that mTOR upregulation plays a major role in determining an aggressive phenotype, thus determining relapse and chemoresistance. Among several activities, mTOR-induced autophagy suppression is key in GBM malignancy. In this article, we discuss recent evidence about mTOR signaling and its role in normal brain development and pathological conditions, with a special emphasis on its role in GBM.
Insights
The mammalian Target of Rapamycin (mTOR) pathway regulates cell growth and is crucial in brain development. Its upregulation is linked to aggressive brain tumors like Glioblastoma Multiforme (GBM), contributing to poor outcomes.
Area of Science:
- Molecular Biology
- Oncology
- Neuroscience
Background:
- The mammalian Target of Rapamycin (mTOR) is a kinase complex vital for cell viability and metabolic regulation.
- mTOR integrates environmental signals to control cell growth, proliferation, autophagy, and protein synthesis.
- Aberrant mTOR signaling is implicated in diseases including obesity, neurodegeneration, and brain tumors.
Purpose of the Study:
- To review the role of mTOR signaling in normal brain development.
- To discuss the pathological implications of mTOR upregulation, particularly in high-grade gliomas.
- To emphasize mTOR's specific role in Glioblastoma Multiforme (GBM) malignancy.
Main Methods:
- Literature review of experimental and pathological findings.
- Analysis of mTOR's function in cellular processes.
- Examination of mTOR's association with tumor aggressiveness and treatment resistance.
Main Results:
- mTOR upregulation is associated with aggressive phenotypes in high-grade gliomas.
- mTOR plays a key role in Glioblastoma Multiforme (GBM) malignancy, promoting proliferation and invasion.
- mTOR-induced autophagy suppression is a critical factor in GBM progression and chemoresistance.
Conclusions:
- mTOR signaling is a significant driver of GBM aggressiveness, relapse, and chemoresistance.
- Targeting mTOR pathways may offer therapeutic strategies for GBM patients.
- Understanding mTOR's role is crucial for developing effective treatments for this lethal brain tumor.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Mitogens and the Cell Cycle
Abnormal Proliferation